|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-5-14
|
|
pubmed:abstractText |
Surgery and radiation are the mainstays of therapy for human gliomas that are the most common primary brain tumors. Most recently, cell culture and animal studies provided the first convincing evidence that radiation not only eliminates tumor cells, but also modulates the immune response and likely improves anti-tumor immunotherapy.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-11051238,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-11242102,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-11464277,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-11703362,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-11857388,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-11937180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-12800201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-15758009,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-15906353,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-15951997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-16636135,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-16865272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-17431391,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18478111-6251993
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1932-6203
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e2164
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18478111-Adult,
pubmed-meshheading:18478111-Aged,
pubmed-meshheading:18478111-Animals,
pubmed-meshheading:18478111-Antigens, Neoplasm,
pubmed-meshheading:18478111-Brain Neoplasms,
pubmed-meshheading:18478111-Cell Line,
pubmed-meshheading:18478111-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18478111-Female,
pubmed-meshheading:18478111-Glioblastoma,
pubmed-meshheading:18478111-Humans,
pubmed-meshheading:18478111-Male,
pubmed-meshheading:18478111-Middle Aged,
pubmed-meshheading:18478111-Spodoptera,
pubmed-meshheading:18478111-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation.
|
|
pubmed:affiliation |
Department of Human Genetics, Saarland University Medical School, Homburg/Saar, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
